Nonviral delivery of genetic medicine for therapeutic angiogenesis

Lloyd-Jones, 2009, Heart disease and stroke statistics–2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Circulation, 119, e21 Kusano, 2005, Sonic hedgehog myocardial gene therapy: tissue repair through transient reconstitution of embryonic signaling, Nat. Med., 11, 1197, 10.1038/nm1313 Hirsch, 2001, Peripheral arterial disease detection, awareness, and treatment in primary care, JAMA, 286, 1317, 10.1001/jama.286.11.1317 Nikol, 2008, Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia, Mol. Ther., 16, 972, 10.1038/mt.2008.33 Bertele, 1999, Clinical outcome and its predictors in 1560 patients with critical leg ischaemia. Chronic Critical Leg Ischaemia Group, Eur. J. Vasc. Endovasc. Surg., 18, 401, 10.1053/ejvs.1999.0934 Brewster, 2006, Cardiovascular gene delivery: the good road is awaiting, Adv. Drug Deliv. Rev., 58, 604, 10.1016/j.addr.2006.03.002 Whitlock, 2004, Adenovirus-mediated transfer of a minigene expressing multiple isoforms of VEGF is more effective at inducing angiogenesis than comparable vectors expressing individual VEGF cDNAs, Mol. Ther., 9, 67, 10.1016/j.ymthe.2003.09.014 Rutanen, 2004, Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart, Circulation, 109, 1029, 10.1161/01.CIR.0000115519.03688.A2 Lazarous, 1999, Adenoviral-mediated gene transfer induces sustained pericardial VEGF expression in dogs: effect on myocardial angiogenesis, Cardiovasc. Res., 44, 294, 10.1016/S0008-6363(99)00203-5 Patel, 1999, Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121, Hum. Gene Ther., 10, 1331, 10.1089/10430349950018012 Garcia-Martinez, 1999, Angiogenesis induced in muscle by a recombinant adenovirus expressing functional isoforms of basic fibroblast growth factor, Gene Ther., 6, 1210, 10.1038/sj.gt.3300950 Ueda, 1999, Gene transfection of hepatocyte growth factor attenuates reperfusion injury in the heart, Ann. Thorac. Surg., 67, 1726, 10.1016/S0003-4975(99)00279-9 Rosengart, 1999, Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease, Circulation, 100, 468, 10.1161/01.CIR.100.5.468 Giordano, 1996, Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart, Nat. Med., 2, 534, 10.1038/nm0596-534 Edelstein, 2007, Gene therapy clinical trials worldwide to 2007 — an update, J. Gene Med., 9, 833, 10.1002/jgm.1100 Thomas, 2003, Progress and problems with the use of viral vectors for gene therapy, Nat. Rev. Genet., 4, 346, 10.1038/nrg1066 Hughes, 2007, Therapy on trial, Nat. Med., 13, 1008, 10.1038/nm0907-1008 Hollon, 2000, Researchers and regulators reflect on first gene therapy death, Nat. Med., 6, 6, 10.1038/71545 Check, 2005, Gene therapy put on hold as third child develops cancer, Nature, 433, 561 Green, 2008, A combinatorial polymer library approach yields insight into nonviral gene delivery, Acc. Chem. Res., 41, 749, 10.1021/ar7002336 Putnam, 2006, Polymers for gene delivery across length scales, Nat. Mater., 5, 439, 10.1038/nmat1645 Yockman, 2008, Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction, J. Control Release, 132, 260, 10.1016/j.jconrel.2008.06.024 Tsurumi, 1996, Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion, Circulation, 94, 3281, 10.1161/01.CIR.94.12.3281 Tio, 1999, Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium, Hum. Gene Ther., 10, 2953, 10.1089/10430349950016366 Heilmann, 2002, Comparison of protein with DNA therapy for chronic myocardial ischemia using fibroblast growth factor-2, Eur. J. Cardiothorac. Surg., 22, 957, 10.1016/S1010-7940(02)00577-8 Taniyama, 2001, Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease, Gene Ther., 8, 181, 10.1038/sj.gt.3301379 Rabinovsky, 2004, Insulin-like growth factor I plasmid therapy promotes in vivo angiogenesis, Mol. Ther., 9, 46, 10.1016/j.ymthe.2003.10.003 Shyu, 1998, Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb, Circulation, 98, 2081, 10.1161/01.CIR.98.19.2081 Qian, 2006, Effective treatment of vascular endothelial growth factor refractory hindlimb ischemia by a mutant endothelial nitric oxide synthase gene, Gene Ther., 13, 1342, 10.1038/sj.gt.3302781 Namba, 2003, Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model, Circulation, 108, 2250, 10.1161/01.CIR.0000093190.53478.78 Wilson, 2006, Netrins promote developmental and therapeutic angiogenesis, Science, 313, 640, 10.1126/science.1124704 Sugano, 2004, Intramuscular gene transfer of soluble tumor necrosis factor-alpha receptor 1 activates vascular endothelial growth factor receptor and accelerates angiogenesis in a rat model of hindlimb ischemia, Circulation, 109, 797, 10.1161/01.CIR.0000112579.61522.67 Sugano, 2004, In vivo transfer of soluble TNF-alpha receptor 1 gene improves cardiac function and reduces infarct size after myocardial infarction in rats, FASEB J., 18, 911, 10.1096/fj.03-1148fje Hiasa, 2004, Circulation, 109, 2454, 10.1161/01.CIR.0000128213.96779.61 Herweijer, 2003, Progress and prospects: naked DNA gene transfer and therapy, Gene Ther., 10, 453, 10.1038/sj.gt.3301983 Brito, 2008, Poly(beta-amino ester) and cationic phospholipid-based lipopolyplexes for gene delivery and transfection in human aortic endothelial and smooth muscle cells, Biomacromolecules, 9, 1179, 10.1021/bm7011373 Xu, 2006, Biodegradable cationic polyester as an efficient carrier for gene delivery to neonatal cardiomyocytes, Biotechnol. Bioeng., 95, 893, 10.1002/bit.21036 Nam, 2009, Biodegradable PAMAM ester for enhanced transfection efficiency with low cytotoxicity, Biomaterials, 30, 665, 10.1016/j.biomaterials.2008.10.013 Zaric, 2004, Effective polyethylenimine-mediated gene transfer into human endothelial cells, J. Gene Med., 6, 176, 10.1002/jgm.484 Ishikawa, 2008, Enhancement of star vector-based gene delivery to endothelial cells by addition of RGD-peptide, Bioconjug. Chem., 19, 558, 10.1021/bc700385r Yu, 2001, TerplexDNA gene carrier system targeting artery wall cells, J. Control. Release, 72, 179, 10.1016/S0168-3659(01)00274-7 Putnam, 2001, Polymer-based gene delivery with low cytotoxicity by a unique balance of side-chain termini, Proc. Natl. Acad. Sci. U. S. A., 98, 1200, 10.1073/pnas.98.3.1200 Jeon, 2008, Heparin-conjugated polyethylenimine for gene delivery, J. Control. Release, 132, 236, 10.1016/j.jconrel.2008.05.017 Du, 2007, Protein adsorption on polyurethane catheters modified with a novel antithrombin–heparin covalent complex, J. Biomed. Mater. Res. A, 80, 216, 10.1002/jbm.a.30977 Han, 1989, Evaluation of blood compatibility of PEO grafted and heparin immobilized polyurethanes, J. Biomed. Mater. Res., 23, 211, 10.1002/jbm.820231309 Lee, 2003, Water-soluble lipopolymer as an efficient carrier for gene delivery to myocardium, Gene Ther., 10, 585, 10.1038/sj.gt.3301938 Lee, 2003, Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer, Gene Ther., 10, 1535, 10.1038/sj.gt.3302034 Yockman, 2009, Polymeric gene delivery of ischemia-inducible VEGF significantly attenuates infarct size and apoptosis following myocardial infarct, Gene Ther., 16, 127, 10.1038/gt.2008.146 Yockman, 2003, Tumor regression by repeated intratumoral delivery of water soluble lipopolymers/p2CMVmIL-12 complexes, J. Control. Release, 87, 177, 10.1016/S0168-3659(02)00362-0 Zhang, 2004, Pharmaco attributes of dioleoylphosphatidylethanolamine/cholesterylhemisuccinate liposomes containing different types of cleavable lipopolymers, Pharmacol. Res., 49, 185, 10.1016/j.phrs.2003.09.003 Golda, 2007, Small poly-l-lysines improve cationic lipid-mediated gene transfer in vascular cells in vitro and in vivo, J. Vasc. Res., 44, 273, 10.1159/000101449 Anwer, 2004, Peptide-mediated gene transfer of cationic lipid/plasmid DNA complexes to endothelial cells, J. Drug Target., 12, 215, 10.1080/10611860410001724468 Driessen, 2008, Development of peptide-targeted lipoplexes to CXCR4-expressing rat glioma cells and rat proliferating endothelial cells, Mol. Ther., 16, 516, 10.1038/sj.mt.6300388 Lampela, 2003, Different synergistic roles of small polyethylenimine and Dosper in gene delivery, J. Control. Release, 88, 173, 10.1016/S0168-3659(02)00489-3 Eastman, 1997, Biophysical characterization of cationic lipid: DNA complexes, Biochim. Biophys. Acta, 1325, 41, 10.1016/S0005-2736(96)00242-8 Zelphati, 1996, Mechanism of oligonucleotide release from cationic liposomes, Proc. Natl. Acad. Sci. U. S. A., 93, 11493, 10.1073/pnas.93.21.11493 Xu, 1996, Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection, Biochemistry, 35, 5616, 10.1021/bi9602019 Faneca, 2002, Evaluation of lipid-based reagents to mediate intracellular gene delivery, Biochim. Biophys. Acta, 1567, 23, 10.1016/S0005-2736(02)00545-X Leong-Poi, 2007, Therapeutic arteriogenesis by ultrasound-mediated VEGF165 plasmid gene delivery to chronically ischemic skeletal muscle, Circ. Res., 101, 295, 10.1161/CIRCRESAHA.107.148676 Bekeredjian, 2003, Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart, Circulation, 108, 1022, 10.1161/01.CIR.0000084535.35435.AE Torchilin, 2003, Cell transfection in vitro and in vivo with nontoxic TAT peptide–liposome–DNA complexes, Proc. Natl. Acad. Sci. U. S. A., 100, 1972, 10.1073/pnas.0435906100 Ko, 2009, Gene delivery into ischemic myocardium by double-targeted lipoplexes with anti-myosin antibody and TAT peptide, Gene Ther., 16, 52, 10.1038/gt.2008.135 Pack, 2005, Design and development of polymers for gene delivery, Nat. Rev. Drug Discov., 4, 581, 10.1038/nrd1775 Yang, 2009, HPMA polymer-based site-specific delivery of oligonucleotides to hepatic stellate cells, Bioconjug. Chem., 20, 213, 10.1021/bc800237t Storrie, 2006, Sustained delivery of plasmid DNA from polymeric scaffolds for tissue engineering, Adv. Drug Deliv. Rev., 58, 500, 10.1016/j.addr.2006.03.004 Gounis, 2005, Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle, Gene Ther., 12, 762, 10.1038/sj.gt.3302481 Folkman, 1995, Angiogenesis in cancer, vascular, rheumatoid and other disease, Nat. Med., 1, 27, 10.1038/nm0195-27 Jang, 2005, Plasmid delivery in vivo from porous tissue-engineering scaffolds: transgene expression and cellular transfection, Mol. Ther., 12, 475, 10.1016/j.ymthe.2005.03.036 Mao, 2009, Enhanced angiogenesis of porous collagen scaffolds by incorporation of TMC/DNA complexes encoding vascular endothelial growth factor, Acta Biomater., 5, 2983, 10.1016/j.actbio.2009.04.004 Doukas, 2002, Delivery of FGF genes to wound repair cells enhances arteriogenesis and myogenesis in skeletal muscle, Mol. Ther., 5, 517, 10.1006/mthe.2002.0579 Shea, 1999, DNA delivery from polymer matrices for tissue engineering, Nat. Biotechnol., 17, 551, 10.1038/9853 Kasahara, 2003, Biodegradable gelatin hydrogel potentiates the angiogenic effect of fibroblast growth factor 4 plasmid in rabbit hindlimb ischemia, J. Am. Coll. Cardiol., 41, 1056, 10.1016/S0735-1097(02)03007-3 Kong, 2008, Design of biodegradable hydrogel for the local and sustained delivery of angiogenic plasmid DNA, Pharm. Res., 25, 1230, 10.1007/s11095-007-9526-7 Trentin, 2006, Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis, Proc. Natl. Acad. Sci. U. S. A., 103, 2506, 10.1073/pnas.0505964102 Panyam, 2002, Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery, FASEB J., 16, 1217, 10.1096/fj.02-0088com Kang, 2008, Nanosphere-mediated delivery of vascular endothelial growth factor gene for therapeutic angiogenesis in mouse ischemic limbs, Biomaterials, 29, 1109, 10.1016/j.biomaterials.2007.11.004 Yi, 2006, Formulation and characterization of poly (D, L-lactide-co-glycolide) nanoparticle containing vascular endothelial growth factor for gene delivery, J. Clin. Pharm. Ther., 31, 43, 10.1111/j.1365-2710.2006.00702.x Klugherz, 2000, Gene delivery from a DNA controlled-release stent in porcine coronary arteries, Nat. Biotechnol., 18, 1181, 10.1038/81176 Perlstein, 2003, DNA delivery from an intravascular stent with a denatured collagen-polylactic-polyglycolic acid-controlled release coating: mechanisms of enhanced transfection, Gene Ther., 10, 1420, 10.1038/sj.gt.3302043 Walter, 2004, Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis, Circulation, 110, 36, 10.1161/01.CIR.0000133324.38115.0A Egashira, 2007, Local delivery of anti-monocyte chemoattractant protein-1 by gene-eluting stents attenuates in-stent stenosis in rabbits and monkeys, Arterioscler. Thromb. Vasc. Biol., 27, 2563, 10.1161/ATVBAHA.107.154609 Zhong, 2009, Gene transduction into aortic wall using plasmid-loaded cationized gelatin hydrogel-coated polyester stent graft, J. Vasc. Surg., 50, 1433, 10.1016/j.jvs.2009.07.071 Takemoto, 2009, Human placental ectonucleoside triphosphate diphosphohydrolase gene transfer via gelatin-coated stents prevents in-stent thrombosis, Arterioscler. Thromb. Vasc. Biol., 29, 857, 10.1161/ATVBAHA.109.186429 Ou, 2010, Polymer transfected primary myoblasts mediated efficient gene expression and angiogenic proliferation, J. Control. Release, 142, 61, 10.1016/j.jconrel.2009.09.021 Neuhuber, 2002, High efficiency transfection of primary skeletal muscle cells with lipid-based reagents, Muscle Nerve, 26, 136, 10.1002/mus.10171 Lu, 2003, Non-viral gene delivery in skeletal muscle: a protein factory, Gene Ther., 10, 131, 10.1038/sj.gt.3301874 Helbling-Leclerc, 1999, Cellular uptake of cationic lipid/DNA complexes by cultured myoblasts and myotubes, Biochim. Biophys. Acta, 1418, 165, 10.1016/S0005-2736(99)00012-7 Lemieux, 2000, A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle, Gene Ther., 7, 986, 10.1038/sj.gt.3301189 Mumper, 1996, Polyvinyl derivatives as novel interactive polymers for controlled gene delivery to muscle, Pharm. Res., 13, 701, 10.1023/A:1016039330870 Ruponen, 2001, Extracellular glycosaminoglycans modify cellular trafficking of lipoplexes and polyplexes, J. Biol. Chem., 276, 33875, 10.1074/jbc.M011553200 Yau, 2005, Maximizing ventricular function with multimodal cell-based gene therapy, Circulation, 112, I123, 10.1161/CIRCULATIONAHA.104.525147 Yau, 2007, Enhanced angiogenesis with multimodal cell-based gene therapy, Ann. Thorac. Surg., 83, 1110, 10.1016/j.athoracsur.2006.10.050 Yang, 2007, Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction, Cardiology, 107, 17, 10.1159/000093609 Ye, 2008, Angiomyogenesis using liposome based vascular endothelial growth factor-165 transfection with skeletal myoblast for cardiac repair, Biomaterials, 29, 2125, 10.1016/j.biomaterials.2008.01.014 Ye, 2007, Transplantation of nanoparticle transfected skeletal myoblasts overexpressing vascular endothelial growth factor-165 for cardiac repair, Circulation, 116, I113, 10.1161/CIRCULATIONAHA.106.680124 Zhang, 2007, SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction, FASEB J., 21, 3197, 10.1096/fj.06-6558com Elmadbouh, 2007, Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium, J. Mol. Cell. Cardiol., 42, 792, 10.1016/j.yjmcc.2007.02.001 Askari, 2003, Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy, Lancet, 362, 697, 10.1016/S0140-6736(03)14232-8 Li, 2007, Bcl-2 engineered MSCs inhibited apoptosis and improved heart function, Stem Cells, 25, 2118, 10.1634/stemcells.2006-0771 Tang, 2005, Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector, J. Am. Coll. Cardiol., 46, 1339, 10.1016/j.jacc.2005.05.079 Jo, 2007, Transplantation of genetically engineered mesenchymal stem cells improves cardiac function in rats with myocardial infarction: benefit of a novel nonviral vector, cationized dextran, Tissue Eng., 13, 313, 10.1089/ten.2006.0133 Song, 2007, Tissue transglutaminase is essential for integrin-mediated survival of bone marrow-derived mesenchymal stem cells, Stem Cells, 25, 1431, 10.1634/stemcells.2006-0467 Schuldiner, 2003, Selective ablation of human embryonic stem cells expressing a “suicide” gene, Stem Cells, 21, 257, 10.1634/stemcells.21-3-257 Whitehead, 2009, Knocking down barriers: advances in siRNA delivery, Nat. Rev. Drug Discov., 8, 129, 10.1038/nrd2742 Sugano, 2005, RNA interference targeting SHP-1 attenuates myocardial infarction in rats, FASEB J., 19, 2054, 10.1096/fj.05-4020fje Sugano, 2007, SiRNA targeting SHP-1 accelerates angiogenesis in a rat model of hindlimb ischemia, Atherosclerosis, 191, 33, 10.1016/j.atherosclerosis.2006.04.021 Guo, 2000, Tumor necrosis factor employs a protein-tyrosine phosphatase to inhibit activation of KDR and vascular endothelial cell growth factor-induced endothelial cell proliferation, J. Biol. Chem., 275, 11216, 10.1074/jbc.275.15.11216 Cho, 2008, Delivery of small interfering RNA for inhibition of endothelial cell apoptosis by hypoxia and serum deprivation, Biochem. Biophys. Res. Commun., 376, 158, 10.1016/j.bbrc.2008.08.123 Bonauer, 2009, MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice, Science, 324, 1710, 10.1126/science.1174381 Huang, 2008, Short hairpin RNA interference therapy for ischemic heart disease, Circulation, 118, S226, 10.1161/CIRCULATIONAHA.107.760785 Wu, 2008, Enhancement of angiogenesis through stabilization of hypoxia-inducible factor-1 by silencing prolyl hydroxylase domain-2 gene, Mol. Ther., 16, 1227, 10.1038/mt.2008.90 Natarajan, 2006, Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury, Circ. Res., 98, 133, 10.1161/01.RES.0000197816.63513.27 Natarajan, 2007, Activation of hypoxia-inducible factor-1 via prolyl-4 hydoxylase-2 gene silencing attenuates acute inflammatory responses in postischemic myocardium, Am. J. Physiol. Heart Circ. Physiol., 293, H1571, 10.1152/ajpheart.00291.2007 Isner, 1996, Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb, Lancet, 348, 370, 10.1016/S0140-6736(96)03361-2 Baumgartner, 1998, Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia, Circulation, 97, 1114, 10.1161/01.CIR.97.12.1114 Kim, 2004, Vascular endothelial growth factor-induced angiogenic gene therapy in patients with peripheral artery disease, Exp. Mol. Med., 36, 336, 10.1038/emm.2004.44 Losordo, 1998, Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia, Circulation, 98, 2800, 10.1161/01.CIR.98.25.2800 Losordo, 2002, Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia, Circulation, 105, 2012, 10.1161/01.CIR.0000015982.70785.B7 Fortuin, 2003, One-year follow-up of direct myocardial gene transfer of vascular endothelial growth factor-2 using naked plasmid deoxyribonucleic acid by way of thoracotomy in no-option patients, Am. J. Cardiol., 92, 436, 10.1016/S0002-9149(03)00661-1 Reilly, 2005, Long-term (2-year) clinical events following transthoracic intramyocardial gene transfer of VEGF-2 in no-option patients, J. Interv. Cardiol., 18, 27, 10.1111/j.1540-8183.2005.04026.x Hedman, 2009, Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer, Gene Ther., 16, 629, 10.1038/gt.2009.4 Baumgartner, 2009, Local gene transfer and expression following intramuscular administration of FGF-1 plasmid DNA in patients with critical limb ischemia, Mol. Ther., 17, 914, 10.1038/mt.2009.24 Morishita, 2004, Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease, Hypertension, 44, 203, 10.1161/01.HYP.0000136394.08900.ed Gaffney, 2007, Cardiovascular gene therapy: current status and therapeutic potential, Br. J. Pharmacol., 152, 175, 10.1038/sj.bjp.0707315 Kusumanto, 2006, Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial, Hum. Gene Ther., 17, 683, 10.1089/hum.2006.17.683 Powell, 2008, Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia, Circulation, 118, 58, 10.1161/CIRCULATIONAHA.107.727347 Laitinen, 2000, Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty, Hum. Gene Ther., 11, 263, 10.1089/10430340050016003 Hedman, 2003, Circulation, 107, 2677, 10.1161/01.CIR.0000070540.80780.92 Merdan, 2002, Prospects for cationic polymers in gene and oligonucleotide therapy against cancer, Adv. Drug Deliv. Rev., 54, 715, 10.1016/S0169-409X(02)00046-7 Suh, 2002, An angiogenic, endothelial-cell-targeted polymeric gene carrier, Mol. Ther., 6, 664, 10.1016/S1525-0016(02)90721-5 Anderson, 2003, Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery, Angew. Chem. Int. Ed. Engl., 42, 3153, 10.1002/anie.200351244 Lynn, 2001, Accelerated discovery of synthetic transfection vectors: parallel synthesis and screening of a degradable polymer library, J. Am. Chem. Soc., 123, 8155, 10.1021/ja016288p Akinc, 2008, A combinatorial library of lipid-like materials for delivery of RNAi therapeutics, Nat. Biotechnol., 26, 561, 10.1038/nbt1402 Akinc, 2002, Measuring the pH environment of DNA delivered using nonviral vectors: implications for lysosomal trafficking, Biotechnol. Bioeng., 78, 503, 10.1002/bit.20215 Green, 2006, Biodegradable polymeric vectors for gene delivery to human endothelial cells, Bioconjug. Chem., 17, 1162, 10.1021/bc0600968 Zugates, 2007, Rapid optimization of gene delivery by parallel end-modification of poly(beta-amino ester)s, Mol. Ther., 15, 1306, 10.1038/sj.mt.6300132 Sunshine, 2009, Small-molecule end-groups of linear polymer determine cell-type gene-delivery efficacy, Adv. Mater., 21, 4947, 10.1002/adma.200901718 Anderson, 2005, Structure/property studies of polymeric gene delivery using a library of poly(beta-amino esters), Mol. Ther., 11, 426, 10.1016/j.ymthe.2004.11.015 Anderson, 2004, A polymer library approach to suicide gene therapy for cancer, Proc. Natl. Acad. Sci. U. S. A., 101, 16028, 10.1073/pnas.0407218101 Huang, 2009, Nanoparticle-delivered suicide gene therapy effectively reduces ovarian tumor burden in mice, Cancer Res., 69, 6184, 10.1158/0008-5472.CAN-09-0061 Green, 2007, Combinatorial modification of degradable polymers enables transfection of human cells comparable to adenovirus, Adv. Mater., 19, 2836, 10.1002/adma.200700371 Yang, 2009, Gene delivery to human adult and embryonic cell-derived stem cells using biodegradable nanoparticulate polymeric vectors, Gene Ther., 16, 533, 10.1038/gt.2008.182 Green, 2008, Nanoparticles for gene transfer to human embryonic stem cell colonies, Nano Lett., 8, 3126, 10.1021/nl8012665 Yang, 2010, Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles, Proc. Natl. Acad. Sci. U. S. A., 107, 3317, 10.1073/pnas.0905432106 Akinc, 2009, Development of lipidoid-siRNA formulations for systemic delivery to the liver, Mol. Ther., 17, 872, 10.1038/mt.2009.36 Frank-Kamenetsky, 2008, Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates, Proc. Natl. Acad. Sci. U. S. A., 105, 11915, 10.1073/pnas.0805434105 Huang, 2009, Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis, Proc. Natl. Acad. Sci. U. S. A., 106, 3426, 10.1073/pnas.0813348106 Cho, 2009, Lipid-like nanoparticles for small interfering RNA delivery to endothelial cells, Adv. Funct. Mater., 19, 3112, 10.1002/adfm.200900519 Hood, 2002, Tumor regression by targeted gene delivery to the neovasculature, Science, 296, 2404, 10.1126/science.1070200 Anand, 2010, MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis, Nat. Med., 16, 909, 10.1038/nm.2186